1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow casimersen: new trials by email Literature Review of casimersen trials Research Report on casimersen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy Casimersen, Golodirsen - Duchenne Muscular Dystrophy | Phase 3 | Terminated | Sarepta Therapeutics, Inc. | 171 | 2018-08-02 | 2024-09-19 |
| Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) SRP-4045, SRP-4053, Placebo - Duchenne Muscular Dystrophy | Phase 3 | Completed | Sarepta Therapeutics, Inc. | 228 | 2016-09-28 | 2025-11-18 |
Muscular Dystrophy, Duchenne (2)
Sarepta Therapeutics, Inc. (2)
Belgium (2) · Bulgaria (2) · Canada (2) · Czechia (2) · France (2) · Germany (2) · Israel (2) · Italy (2) · Poland (2) · Spain (2) · Sweden (2) · United Kingdom (2) · United States (2) · Argentina (1) · Australia (1)
2015 (1), 2017 (1)